TOP TIERMARKET NEWSWIRE
News & sentiment

IOVANCE BIOTHERAPEUT (IOVA) — News & AI sentiment

IOVANCE BIOTHERAPEUT (IOVA) news roundup. 16 stories aggregated over the last 30 days. Average 30-day sentiment is 56.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
16
avg sentiment 56.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

IOVA news in the last 24 hours, 7 days, 30 days and 90 days

How much IOVA coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIOVA storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1656.5/100IOVA headlines →
Last 90 days5261.6/100IOVA headlines →

Latest stories on IOVA

Iovance Biotherapeutics to Present at Upcoming Conferences
Business Insider56 · neutralproduct/pr
Sep 4
Sep 4
Sep 3
TD Cowen raises Iovance Biotherapeutics price target on sales outlook
Investing.com Analyst Ratings61 · neutralanalyst
Aug 25
Aug 25
Aug 24
Aug 21
Aug 21
Aug 21
Aug 20
Aug 20
UBS raises Iovance Biotherapeutics stock price target on revenue beat
Investing.com Analyst Ratings61 · neutralanalyst
Aug 20
Aug 20
Aug 19
Aug 18
Aug 17
Iovance (IOVA) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Aug 13
Aug 10
Aug 10
Aug 7
Aug 7
Aug 7
Aug 7
Aug 7
Aug 6
Open IOVA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →